These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 22106341

  • 1. Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency.
    Elbornsson M, Götherström G, Franco C, Bengtsson BÅ, Johannsson G, Svensson J.
    Eur J Endocrinol; 2012 Feb; 166(2):181-9. PubMed ID: 22106341
    [Abstract] [Full Text] [Related]

  • 2. Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency.
    Elbornsson M, Götherström G, Bosæus I, Bengtsson BÅ, Johannsson G, Svensson J.
    Eur J Endocrinol; 2012 May; 166(5):787-95. PubMed ID: 22318746
    [Abstract] [Full Text] [Related]

  • 3. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency.
    Götherström G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J.
    Eur J Endocrinol; 2007 Jan; 156(1):55-64. PubMed ID: 17218726
    [Abstract] [Full Text] [Related]

  • 4. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.
    Appelman-Dijkstra NM, Claessen KM, Hamdy NA, Pereira AM, Biermasz NR.
    Clin Endocrinol (Oxf); 2014 Nov; 81(5):727-35. PubMed ID: 24816144
    [Abstract] [Full Text] [Related]

  • 5. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
    Franco C, Johannsson G, Bengtsson BA, Svensson J.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
    [Abstract] [Full Text] [Related]

  • 6. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
    Drake WM, Rodríguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP.
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789
    [Abstract] [Full Text] [Related]

  • 7. TRABECULAR BONE SCORE CHANGE DIFFERS WITH REGARD TO 25(OH)D LEVELS IN PATIENTS TREATED FOR ADULT-ONSET GROWTH HORMONE DEFICIENCY.
    Kužma M, Binkley N, Bednárová A, Killinger Z, Vaňuga P, Payer J.
    Endocr Pract; 2016 Aug; 22(8):951-8. PubMed ID: 27042750
    [Abstract] [Full Text] [Related]

  • 8. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.
    Johannsson G, Sunnerhagen KS, Svensson J.
    Clin Endocrinol (Oxf); 2004 May; 60(5):550-9. PubMed ID: 15104557
    [Abstract] [Full Text] [Related]

  • 9. Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender.
    Rota F, Savanelli MC, Tauchmanova L, Savastano S, Lombardi G, Colao A, Di Somma C.
    J Endocrinol Invest; 2008 Feb; 31(2):94-102. PubMed ID: 18362499
    [Abstract] [Full Text] [Related]

  • 10. Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation.
    Elbornsson M, Götherström G, Bengtsson BÅ, Johannsson G, Svensson J.
    Growth Horm IGF Res; 2013 Dec; 23(6):249-55. PubMed ID: 24103227
    [Abstract] [Full Text] [Related]

  • 11. Effects of long-term treatment with GH in the bone mineral density of adults with hypopituitarism and GH deficiency and after discontinuation of GH replacement.
    Gómez JM, Gómez N, Fiter J, Soler J.
    Horm Metab Res; 2000 Feb; 32(2):66-70. PubMed ID: 10741688
    [Abstract] [Full Text] [Related]

  • 12. Impact of the growth hormone replacement on bone status in growth hormone deficient adults.
    Kužma M, Kužmová Z, Zelinková Z, Killinger Z, Vaňuga P, Lazurová I, Tomková S, Payer J.
    Growth Horm IGF Res; 2014 Feb; 24(1):22-8. PubMed ID: 24382377
    [Abstract] [Full Text] [Related]

  • 13. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

  • 14. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U, Wilton P, Jonsson P, KIMS Study Group, KIMS International Board.
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [Abstract] [Full Text] [Related]

  • 15. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 16. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents.
    Fors H, Bjarnason R, Wirént L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G.
    Clin Endocrinol (Oxf); 2001 Nov 15; 55(5):617-24. PubMed ID: 11894973
    [Abstract] [Full Text] [Related]

  • 17. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
    Tanriverdi F, Unluhizarci K, Kula M, Guven M, Bayram F, Kelestimur F.
    Growth Horm IGF Res; 2005 Jun 15; 15(3):231-7. PubMed ID: 15921942
    [Abstract] [Full Text] [Related]

  • 18. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G.
    J Clin Endocrinol Metab; 1999 Jun 15; 84(6):1919-24. PubMed ID: 10372687
    [Abstract] [Full Text] [Related]

  • 19. Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis.
    Barake M, Arabi A, Nakhoul N, El-Hajj Fuleihan G, El Ghandour S, Klibanski A, Tritos NA.
    Endocrine; 2018 Jan 15; 59(1):39-49. PubMed ID: 29030774
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone and bone health.
    Bex M, Bouillon R.
    Horm Res; 2003 Jan 15; 60 Suppl 3():80-6. PubMed ID: 14671403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.